Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (15) , 2473-2478
- https://doi.org/10.1016/0006-2952(84)90720-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Structural determination of rat urinary metabolites of sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Decrease of urinary prostaglandin E2 and prostaglandin F2α excretion by nonsteroidal anti-inflammatory drugs in ratsBiochemical Pharmacology, 1983
- Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity studyProstaglandins, 1980
- A new approach to anti-inflammatory drugsBiochemical Pharmacology, 1979
- Prostaglandin (PG) analysis in urine of humans and rats by different radioimmunoassays: Effect on PG-excretion by PG-synthetase inhibitors, laparotomy and furosemideProstaglandins, 1978
- New Aspects of the Mode of Action of Nonsteroid Anti-Inflammatory DrugsAnnual Review of Pharmacology, 1974
- Radioimmunoassay Measurement of Prostaglandins E, A, and F in Human PlasmaJournal of Clinical Investigation, 1973
- Mechanism of prostaglandin biosynthesis. I. Characterization and assay of bovine prostaglandin synthetaseBiochemistry, 1971